WMYD (channel 20) is an independent television station in Detroit, Michigan, United States. It is owned by the E. W. Scripps Company alongside ABC affiliate WXYZ-TV (channel 7). The two stations share studios at Broadcast House on 10 Mile Road in Southfield; WMYD's transmitter is located on Eight Mile Road in Oak Park.

Bodycam video released in Farmington Hills morning fire that injured 4 officers

2019 WCLC公布了一项奥希替尼联合西妥昔单抗治疗EGFR 20ins的Ⅰ期扩展队列结果，最终4例患者可评估疗效，2例患者部分缓解， ORR为50%，中位 PFS为5.3个月。 中山大学肿瘤防治中心的张力教授团队进行了一项奥希替尼治疗EGFR 20ins患者的回顾性研究。 研究中有6例EGFR 20ins的晚期肺腺癌患者接受奥希替尼治疗，4例患者出现肺和胸膜的转移，患者5为脑转移，患者6为骨转移。 2例患者接受奥希替尼一线治疗，其他都是≥2线治疗，且其中2例患者在奥希替尼 …

2023年10月21日 · Amivantamab has been approved for the treatment of patients with advanced non–small-cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertions who have had disease...

7 News Detroit at 10pm on TV 20 New. Breaking news and headlines, local weather forecasts, sports and traffic reports.

Give Light and the People Will Find Their Own Way

2019年7月8日 · EGFR罕见突变约占15%～20%，其中EGFR exon 20ins（EGFR 20号外显子插入）突变是最常见的罕见突变，约占罕见突变的一半，这类患者对目前已经 获批的EGFR-TKI的治疗相对不敏感，亟需探索新的有效药物。

2024年4月5日 · What Causes an Exon 20 Insertion Mutation? Getting a Diagnosis; Questions for Your Doctor; How Is an Exon 20 Insertion Mutation Treated?

Background: Epidermal growth factor receptor gene (EGFR) exon 20 insertion (ex20-ins) mutations are an uncommon and heterogeneous group of non-small cell lung cancers (NSCLCs), resistant to conventional EGFR tyrosine kinase inhibitors (TKIs). Characteristics and outcomes of patients with EGFR ex20-ins have not been fully established; we sought ...

WXON, virtual channel 20 (UHF digital channel 21), is a MyNetworkTV-affiliated television station licensed to Detroit, Michigan, United States. The station is owned by the E. W. Scripps Company. WXON's studios are located at the American Center Building on Franklin Road in Southfield.